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a  b  s  t  r  a  c  t
EuroStemCell  is a large  and  growing  network  of  organizations  and individuals  focused  on  public  engage-
ment  with  stem  cells  and  regenerative  medicine  – a fluid  and  contested  domain,  where  scientific,  political,
ethical,  legal  and  societal  perspectives  intersect.  Rooted  in  the  European  stem  cell  research  community,
this  project  has  developed  collaborative  and  innovative  approaches  to information  provision  and  direct
and  online  engagement,  that  reflect  and  respond  to the dynamic  growth  of the  field  itself.  EuroStem-
Cell  started  as  the  communication  and  outreach  component  of  a research  consortium  and  subsequently
continued  as a stand-alone  engagement  initiative.  The  involvement  of  established  European  stem  cell sci-
entists  has grown  year-on-year,  facilitating  their  participation  in  public  engagement  by  allowing  them  to
make  high-value  contributions  with  broad  reach.  The  project  has  now  had  sustained  support  by  partnersigital engagement
urope
and  funders  for over  twelve  years,  and thus  provides  a model  for longevity  in  public  engagement  efforts.
This paper  considers  the evolution  of  the  EuroStemCell  project  in  response  to  – and  in  dialogue  with  –  its
evolving  environment.  In it,  we  aim  to reveal  the  mechanisms  and  approaches  taken  by  EuroStemCell,
such  that  others  within  the  scientific  community  can  explore  these  ideas  and  be  further  enabled  in  their
own  public  engagement  endeavours.
© 2017  The  Author(s).  Published  by  Elsevier  Ltd.  This  is  an open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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. Introduction
The stem cell research and regenerative medicine sector excites
nd inspires hope, whilst simultaneously raising new social and
thical concerns. The sector holds promise for developing new
reatments, for conditions such as Parkinson’s disease, multiple
clerosis, macular degeneration and spinal cord injury. This has
ed to continued and significant investment from UK and Euro-
ean governments, with expectations that stem cell research will
timulate economic and scientific growth along with health bene-
ts [1]. The enormous public interest in this emergent technology
herefore comes as no surprise, but does pose challenges around
epresentation and communication in the public domain, particu-
arly in the context of widespread international media and indeed,
ome academic hype [2,3].
In the last ten years, www.eurostemcell.org – the centre-piece of
 wider engagement project called EuroStemCell – has become one
f the world’s premier sources of accessible, scientifically credible,
p-to-date information about stem cell and regenerative medicine
esearch and related societal issues, in 2016 the website reached
 worldwide audience of more than 1.3 million. This leading posi-
ion reflects careful and intentional development of the project,
sing a ‘bottom-up’ approach grounded in dialogic (i.e. reciprocal)
ngagement with audiences and stakeholders. In this article, we
xamine EuroStemCell’s development, and how its goals, remit and
mpact have evolved in step with scientific developments in stem
ell research. We  also share what we have learned about creat-
ng space, opportunities and infrastructure for biologists to engage
ith non-specialists in this fast moving area of science, with the
ope that biologists from other fields will be inspired and helped
o continue this mandate in their arenas.
. Introducing EuroStemCell
Stem cell research is a fast moving area of science, which raises
undamental questions about the nature of life and where it begins.
t also intersects with society on several levels (e.g. organ/tissue
onation, ethics, religion, values, medicine, aging, patienthood). As
uch there are many interest groups who present strong opinions
nd perspectives about stem cell research. EuroStemCell is a public
ngagement initiative that aims to help European citizens navigate
his context to make sense of the research and the impact it has on
ociety and people’s lives. This encompasses stem cell biology and
egenerative medicine in the broadest sense, from basic research
o ethical and societal issues. EuroStemCell’s core mission, estab-
ished in 2010, is to help European citizens make sense of stem cells.
o achieve this, the project has continuously evolved in response to
udience demand and evaluation. As part of this evolution, the need
o actively help stem cell researchers make sense of public engagement
as identified and, in response, the project has developed strategic
ctions in capacity building and sharing of best practice in public
ngagement. Fig. 1 outlines the structure of the project in 2017.
A central mechanism for achieving these missions is the
roject’s multilingual website, www.eurostemcell.org, (Fig. 2),
hich is founded in a systematic and collaborative approach to
ollating and ‘packaging’ stem cell and regenerative medicine infor-
ation – from historical perspectives to synthesized contemporary
nowledge and research updates. Core content is written in plain
anguage, accessible to non-specialists, and reviewed by subject
atter experts and, in some cases, a representative of the target
udience (e.g. patient, teacher) prior to publication. All content isPlease cite this article in press as: J. Barfoot, et al., EuroStemCell: A Eu
stem cell research, Semin Cell Dev Biol (2017), http://dx.doi.org/10.10
ully attributed, so that the author(s) and reviewer(s) of each arti-
le, and their expertise and affiliations, are clear to the reader –
ontrasting the knee-jerk fast output/response to research findings
hat can be prevalent in digital spaces. PRESS
mental Biology xxx (2017) xxx–xxx
Through working with multiple network members, EuroStem-
Cell can offer ‘synthesized commentary’ on a given aspect of stem
cell research rather than the single opinion of one research group.
Consequently, a more complete, high quality, picture of the field can
be built up in a single location, and can easily be found by different
audiences and stakeholders. This approach has the additional ben-
efits of reducing duplication of effort and dramatically increasing
the reach of individual outputs. The website now has a founda-
tion of high quality content that can be repurposed, remixed and
distributed across multiple channels. EuroStemCell also supports
development of targeted tools for public and schools engagement
with stem cell research – often through partnership – and seeks
to collate relevant engagement methodologies and activities and
make them available for widespread use [5].
EuroStemCell has a ‘hub and spoke’ structure. The ‘hub’ team at
the University of Edinburgh co-ordinates the project. The thirty-
four current core partner institutions include the coordinating
partners of many European Commission (EC) stem cell research
consortia, and European national and regional stem cell networks.
At the funding proposal stage these partners agreed to provide
academic, in-kind and in some cases financial support for the
project. The partners also use EuroStemCell as a route to dissemi-
nate their scientific outputs, where appropriate, and as a centralised
resource for accessing training and tools for delivering public
engagement activities. This reciprocal synergistic relationship pro-
vides incentive within the partnership. Each partner provides at
least one senior scientist and one communications professional as
key network contacts. Through and beyond the formal partnership,
EuroStemCell’s network extends to include organisations across
Europe. Subject matter experts – scientists, ethicists, social scien-
tists, clinicians, patient representatives and others – who  are active
in stem cell research and support the work of the project can be
called on for comment and to write and review content. Most mem-
bers of this ‘Network of Expertise’ have received EC or national stem
cell research funding and met  the criteria of these funders’ rigor-
ous review processes – providing an additional layer of trust and
credibility. The entire project (summarised in Fig. 1) is enabled by
the equivalent of two  full time core staff located in a single site,
within the MRC  Centre for Regenerative Medicine at the University
of Edinburgh, whose expertise includes public engagement, schools
education, digital engagement, translation and science communi-
cation. These staff coordinate and manage all aspects of the project
across the six themes.
3. History & evolution of eurostemcell.org
The website eurostemcell.org was  launched in 2004, initially
as a project website intended to serve a research consortium,
funded under the European Commission’s 6th Framework Pro-
gramme  (called EuroStemCell I herein). The goal of EuroStemCell I
was to build the foundations for regenerative medicine, primarily
through research in fundamental stem cell biology, but also through
collaboration, training and outreach activities. The project’s web-
site included information accessible to non-specialist audiences,
such as answers to frequently asked questions about stem cells and
regenerative medicine.
The EuroStemCell website was launched at a time when claims
that adult stem cells could turn into any other sort of cell in the
body were prevalent in the literature – but were beginning to be
disproven (see e.g. [8,9]) – and soon afterwards the discovery of
induced pluripotent stem cells (iPS cells) rocked the biomedicalropean infrastructure for communication and engagement with
16/j.semcdb.2017.08.006
research community [10,11]. At the same time there was grow-
ing awareness amongst academics in the stem cell field and wider
publics of the complex and numerous social, and ethical dimen-
sions of stem cell research [12–14]. Meanwhile, regulators and
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stem cell research and have the opportunity to engage with the
wider research community. The latest digital technologies, includ-
ing social media and a multilingual content management system,ig. 1. Structure of the EuroStemCell project in 2017. The six main areas of work are
rom  within the partnership. The collaboration with external stakeholders is represe
he  permeability of the project to external influences, ideas and trends.
olicy makers were facing the need for new national and inter-
ational regulatory systems to provide quality assurance, control,
tandardization and safety checks for cell-based therapies [15,16].
owever, even those within the stem cell scientific community
ere struggling to develop a clear and consistent understanding
f how stem cells work in the body. Increasingly, it was  recognized
hat there was an unmet need for the coordinated provision of stem
ell research information.
The decision to establish an outreach and communications pro-
ramme  within EuroStemCell I thus arose from an appreciation of
he high hopes for development of new stem cell therapies, and
f the emotive issues surrounding the stem cell field – including
uman cloning and the use of embryos for research. The project
cientists recognized the public interest in their work and felt they
ad a responsibility, and were uniquely positioned, to bring synthe-
ized understanding of this complex field into the public domain
hile addressing counterproductive misconceptions. By engaging
ith the public, including patients and their representatives, they
ould support informed decision-making around stem cell research
nd regenerative medicine – from questions of organ and tissue
onation to treatment choices, funding and political decisions. It
as acknowledged this engagement could also be important for
he development of future stem cell-based therapies.
From 2004 to 2008 therefore, EuroStemCell developed an ambi-
ious public engagement and outreach programme. The project
eam worked in collaboration with filmmakers to produce a series
f short documentaries on the science and ethics of stem cell
esearch – including the award winning ‘A Stem Cell Story’ [17].
hese films were distributed via film festivals and on DVD, and
ere made freely available on the (then) relatively new platform
ouTube. A public information section was established on the
uroStemCell I website – based on the questions consortium partic-
pants received from members of the public and from patients. ThePlease cite this article in press as: J. Barfoot, et al., EuroStemCell: A Eu
stem cell research, Semin Cell Dev Biol (2017), http://dx.doi.org/10.10
utreach and public engagement activities developed in this period
ere further informed by interaction with social scientists through
he “Talking Stem Cells” project led by Dr Sarah Parry at the Univer-
ity of Edinburgh, which aimed to investigate views and concernssented as themes, the work under these themes is advised by small working groups
as a two  way process. The whole project is surrounded by a dotted line to represent
about stem cell research, and explore the scope for increasing public
engagement in the developing field. This interaction – among other
things – led to development of experimental public and schools
events, and introduced the participating scientists to the concept of
dialogical engagement [18], defined at that stage as “a window for
stakeholders and non-stakeholders, scientists and non-scientists to
hear the views of others while sharing their own: an opportunity
for exchanging ideas and mutual learning” [18].
EuroStemCell I ended in 2008, but ongoing public interest in
stem cell research was clear. Project partners continued to receive
enquiries from patients and caregivers, and stem cell research was
never far from the news headlines. In particular, the film ‘A Stem Cell
Story’ received wide acclaim, at science film festivals, among teach-
ers and educational resource providers,1 and with other audience
groups including patients, science funders and politicians. The 15-
min  film has now been viewed on YouTube over 320,000 times and
has been watched for over 29,000 h during its lifetime.
Project partners recognized an opportunity to develop a Europe-
wide infrastructure for public engagement with stem cells and
regenerative medicine that would allow sharing rather than dupli-
cation of effort and know-how. A decision was  therefore reached in
2008, to our knowledge for the first time for a project of this type,
to try to sustain the website and resources beyond the life of the
original scientific research project. Redevelopment and expansion
of the existing project website was  initiated, supported initially by
one existing and three new EU-funded research consortia. The goal
was to put public engagement front and centre, helping European
citizens find trusted, credible and up-to-date information aboutropean infrastructure for communication and engagement with
16/j.semcdb.2017.08.006
1 Best TV/video production, Tromsø Science Media Festival. Best short
film, Scinema (Australia). In competition, Science Film Festival (Bangkok),
BaKaFORUM 2007, Vedere la Scienza. Recommended by Scottish government
agency Learning and Teaching Scotland as a tool for National Qualifications support.
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s well as evolving website design, all supported these objectives
Fig. 2).
Additionally, a new direction emerged for the work of the
roject. Progress in fundamental science and anticipation around
he development of new stem cell therapies created conditions in
hich some organizations could start selling unproven treatments
irectly to patients with incurable conditions. The advertising ofPlease cite this article in press as: J. Barfoot, et al., EuroStemCell: A Eu
stem cell research, Semin Cell Dev Biol (2017), http://dx.doi.org/10.10
hese so called ‘stem cell treatments’ was predominantly under-
aken online and via social media. This phenomenon entered
cientific academic discourse in 2008–9 [19] along with attempts
o provide clear guidelines to address some of the issues [20].st iteration of the website was launched in December 2016.
EuroStemCell responded by broadening its objectives to support
informed decision-making about the clinical use of stem cells. This
included information provision on medicine and stem cells (Table 1,
Section 3), face-to-face discussion events with non-specialists, and
researcher training and support on patient- and public- engage-
ment (Table 1, Section 5). In addition, in-depth articles were
published on the EuroStemCell website, highlighting the clinicalropean infrastructure for communication and engagement with
16/j.semcdb.2017.08.006
trials process, national and European regulatory processes, private
stem cell clinics, stem cell tourism and for-profit clinical trials [6]
– all optimised for search (see Section 5.1.3 for further detail).
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Table  1
Structure of EuroStemCell website and rationale.
Website Section Audience Rationale
Section 1: Explore Stem Cells [4] Formal or informal educationalists,
general interest groups i.e. people in
full-time education, general interest
European citizens, media professionals
or  scholars from other disciplines.
Providing access to current and credible information on stem cells, the
applications of them in research and healthcare, and the social, moral and
ethical implications of their use. Information is synthesised from many
sources, written in clear language in summary and longer form. Further
information provided and provenance of information transparent (e.g. writers,
reviewers, specific research projects, research papers). Filters are used to
allowed people to search for information useful to them.
Section 2: Education [5] Formal or informal educationalists,
public engagement professionals,
scientists involved in public
engagement or outreach activities.
A repository of activities, games, films, materials and resources developed by
EuroStemCell or others. Collated with the aim of reducing duplication of effort
and increasing the quality of educational engagement about stem cell
research. Filters are used to allowed people to search for resources suitable for
their needs.
Section 3: Medicine and Stem Cells [6] People affected by conditions, their
carers, patient advocacy groups,
condition specific charities,
policymakers and healthcare
professionals.
As section 1 above but with focus on specific conditions. In addition, specific
articles address the current applications of stem cell therapies, how to get
involved in stem cell research through clinical trials or patient registries,
making decisions regarding treatment offers and issues around stem cell
tourism.
Section  4: About EuroStemCell [7] Partners, funders, collaborators, future
collaborators, associated projects and
other interested parties.
This section provides information about the structure of the project, how it is
funded, the network, the people and projects involved and the history of
EuroStemCell. It aims to help people assess the credibility, provenance and
scope of the project.
Section 5: Engagement Practitioner
Platform (not publicly available)
Partners and key collaborators. The section contains content specific for partners or public engagement
practitioners. It aims to facilitate efficient functioning of the project and to
share best practice on the public engagement with stem cell research. It
contains: project documents such as annual reports and evaluation reports; a
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cEuroStemCell received its first stand-alone funding from the
uropean Commission’s Seventh Framework Programme in 2010,
s a coordinating and support action. By this time over 86,000 peo-
le per year were visiting the site, and a smaller but significant
umber were accessing the project or its partners via other chan-
els including film screenings, public events, social media, open
ays and schools engagement activities. Audience research per-
ormed by the professional science communicators on the project
sing mixed methods (i.e. online surveys, informal feedback and
ormative discussions with internal and external partners) iden-
ified provision of information as a major priority. In response, a
eries of fact sheets, FAQs, and commentaries on a wide range of
opics in stem cell biology, regenerative medicine and related soci-
tal issues were developed, written in plain language to a defined
emplate and reviewed by experts (usually from within the project
artnership) in the relevant area prior to publication (Table 1,
ections 1 and 3). Specifically to serve the needs of science commu-
icators, educators and scientists – and at their request – a toolkit
f educational materials, e.g. films, comics, lesson plans, games,
ctivities, animations and activities, was developed in partnership
ith other projects. These and other relevant resources identified
hrough interactions with collaborators, partner projects or stake-
olders groups were catalogued in a directory that contained over
00 entries (Table 1, Section 2). These new engagement tools were
esigned for use in both face-to-face engagement activities (i.e.
pen days, school visits, patient visits to laboratories, science festi-
als) and online (e.g. videos, interactive comics, animations), with
uroStemCell offering training and support for researchers in pub-
ic engagement and in using these materials in public settings. The
ublic engagement training provided by EuroStemCell is usually
n the form of sessions scheduled into the programme of scientific
vents like annual meetings, conferences or summer schools.
Multilingual functionality was identified as an essential devel-
pment, and was added to the website from 2011 – translatingPlease cite this article in press as: J. Barfoot, et al., EuroStemCell: A Eu
stem cell research, Semin Cell Dev Biol (2017), http://dx.doi.org/10.10
he interface and key content into English, French, German, Italian,
panish, and Polish and so making the site accessible to more than
0% of Europeans in their first or second language. Social media
hannels including Twitter, Facebook and YouTube were used toEuroStemCell Handbook which contains editorial frameworks and guidance
for partners; resources on public engagement and evaluation and case studies
or  reports of partner engagement activities.
support all communication efforts, providing supplementary con-
versation and dissemination platforms, while raising the profile
and extending the reach of the website, resources and direct public
engagement.
In an audience evaluation, in the form of an online survey
disseminated through our partnership and networks carried out
by a professional external evaluator in 2011, 95% of respondents
(n = 240) felt the website provided reliable information and 86% said
they would recommend it to their colleagues and friends. Under-
pinning all of the project’s actions was  a strong ethos of collective
ownership and development. By 2011 more than 120 scientists,
ethicists, legal experts, science communicators and social scien-
tists from all over Europe had contributed content to the website,
with many more participating in the translation effort.
The project, now in its third iteration, is still funded by the Euro-
pean Commission as a co-ordinating action in the Horizon2020
programme. The website has had over 200 contributors – scientists,
social scientists, ethicists, anthropologists, economists, clinicians,
patient advocates, lawyers, educationalists, public engagement
specialists, writers, film-makers, artists and translators (see Table 1
and Section 4. The collaborative model). In 2016 it received over 1.3
million unique visitors annually from all over the world (Source:
website analytics; see Fig. 3). Many of the original rationales for
the work still exist; for example, due to the challenges of regulating
stem cell therapies and the absence of globally harmonized regula-
tions, unproven therapies continue to be offered in some territories
[21]. Indeed, the marketing of unproven stem cell therapies directly
to consumers has only become more contentious and still poses
a significant threat to the legitimate development of cell-based
therapies [22,23].
4. The collaborative model
EuroStemCell is rooted in the research community and its part-ropean infrastructure for communication and engagement with
16/j.semcdb.2017.08.006
nership model has been instrumental in establishing a project of
sufficient breadth and credibility to stand the test of time. The
project’s credibility is strongly related to the time freely given
by world-leading experts in the field. From the outset, EuroStem-
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dFig. 3. Website growth and social media us
ell had high-level support from a small number of world-leading
enior researchers and some key interdisciplinary partners in the
ocial sciences and bioethics fields. As the project has grown, the
cope of expertise represented by the project has widened [24]
llowing EuroStemCell to address the social, moral and ethical con-
exts of the research as well as the science. The interdisciplinary
spect of the project is of growing importance as the science pro-
resses closer to clinical translation and adoption by healthcare
roviders, and accordingly, fostering appropriate collaborations
as been one of the project’s intentional goals from its early stagesPlease cite this article in press as: J. Barfoot, et al., EuroStemCell: A Eu
stem cell research, Semin Cell Dev Biol (2017), http://dx.doi.org/10.10
f development. Constant evolution is key for maintaining the cred-
bility of the project and its outputs as the sector continues to
evelop. Fig. 4 models the reflexive approach that drives the actions09–2016 (source website analytics, 2017).
of EuroStemCell, showing the interactions that EuroStemCell bro-
kers, whilst representing the agency and movement of the multiple
stakeholders with whom the project works.
5. The EuroStemCell project in 2017
5.1. EuroStemCell: core mission and objectives
EuroStemCell’s core original mission was  to help European cit-ropean infrastructure for communication and engagement with
16/j.semcdb.2017.08.006
izens make sense of stem cells and evolved to encompass helping
the stem cell research community make sense of public engagement.
The project is clearly positioned as an information and resource
provider, and broker of engagement between many different audi-
ARTICLE ING ModelYSCDB-2315; No. of Pages 12
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Fig. 4. EuroStemCell’s collaborative approach. Schematic representation of the
many dialogue-based interactions underpinning and promoted by EuroStemCell.
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like Google to index the content. EuroStemCell consequently ranksMultipliers’ refers to key organizations and initiatives that can expand the reach
f the project, for example, patient advocacy groups, teacher trainers and policy
etworks.
nce groups. These functions depend on its maintaining a position
f trust among its stakeholders and users. Therefore, it has a pol-
cy of openness, underpinned by attribution of all content, and
dditionally has developed a clear non-lobbying stance: although
embers of the network may  have strong views and take lobbying
ctions, this is never a function of the project itself. Overall there-
ore, the project presents a holistic approach to public engagement
n its specialist field, which is delivered through five core strands
f work outlined below.
.2. Developing a European network on public engagement with
tem cell research
The EuroStemCell project exists fundamentally as a network of
tem cell research institutes, networks and organisations with key
ontacts (senior scientists/academics and engagement profession-
ls) in each of these entities. Network members fulfil several roles
or EuroStemCell. First, through the project’s working group struc-
ure, small groups of partners advise and ratify the work which is
arried out in each area of the project (see Fig. 1). These working
roups prioritize topics for consideration and provide expertise for
eview or commentary on those topics. Expertise is also drawn from
utside the stem cell research community. Second, they provide
ccess to the research − through the provision of researchers for
ngagement actions and by providing access to research findings
r clinical trial information as they are released. Finally, they act as
ational champions for the consolidated outputs of the EuroStem-
ell Network, extending the outcomes of the project into new
ocalities and networks.
At the practical level, much of this is achieved through reg-
lar email requests to partners for new research findings or
esources, small working groups (as mentioned above) and a
maller number of structured strategic discussions at EuroStem-
ell workshops, consortia scientific meetings or summer schools.
or actions involving specific stakeholders – for instance people
ffected by conditions and their carers – small focus groups (either
ace-to-face or online) are held with representatives of these stake-
olders in order to formatively shape the action. These approaches
nable a coordinated response to dissemination of, and commen-
ary on, advanced understanding of stem cell research findings andPlease cite this article in press as: J. Barfoot, et al., EuroStemCell: A Eu
stem cell research, Semin Cell Dev Biol (2017), http://dx.doi.org/10.10
evelopments in regenerative medicine. Rather than each research
entre or institute producing their own website and building up a
ocal audience, each contributes to a broader effort designed specif-
cally for European citizens through the EuroStemCell website. PRESS
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5.3. Collaborative development and dissemination of resources
for use in education and in direct and online public engagement
The availability of EuroStemCell’s resources online means that
development and production work undertaken by one group can
be used by other members of the network and, as discussed above,
that the resources can easily be found by different audiences and
stakeholders. EuroStemCell is committed to promoting and shar-
ing good practice in resource development. For instance, outputs
of the project itself are co-produced and prototype-tested with tar-
get audiences (e.g. in classrooms or with teachers) to ensure they
are relevant, accessible and engaging and, in the case of educa-
tional resources, curriculum-compatible [25]. We  have found that
co-development of resources together with target audiences, and
participation in face to face engagement activities around specific
topical issues is essential, as it grounds all of the work of the project
in dialogical engagement with target audiences. An increasing focus
has become the provision of resources to support those who have
to make decisions regarding stem cells and regenerative medicine.
An important strategy that has evolved from this work is collab-
oration with ‘multiplier’ organizations, for instance educational
resource providers (e.g. Scottish Secondary Education Resource
Centre, STEM Learning, TES Resources [26–28]) and patient advo-
cacy organizations (e.g. Parkinsons UK, Scope [29,30]) and, where
appropriate, media organisations such as the Science Media Centre,
which increases the reach of tools and resources developed by the
project and also allows resource validation and/or accreditation by
organizations respected by the intended end-user.
5.4. Digital engagement to maximize EuroStemCell’s reach and
impact
A project with a pan-European remit and limited resources can
only reach a small group of stakeholders face-to-face and therefore
a strategic approach is needed. Digital channels open the possibility
of reaching a much larger and more diverse audience, wherever
they are and in many cases in their own  space.
High quality content that can be translated, repurposed,
remixed and distributed across multiple channels is the backbone
of our digital engagement strategy. There is, however, a signifi-
cant challenge in structuring content to reach the wide range of
digital audiences that EuroStemCell aims to engage. EuroStem-
Cell categorizes these audiences into three groups: general interest
non-specialist, informed non-specialist, and specialist communi-
ties (see Table 2 for examples). These categories allow the project to
meet the needs of a wide variety of audiences. They function to aid
structuring of the information behind the scenes, while the ‘visible’
structure represented on the website is organised to retain flexi-
bility and appeal to diverse audiences (see Table 1), using tagging
and metadata to allow content to surface via appropriate filters.
Dynamic provision of new and updated website content for each
of these audience groups is key to the project’s success, as is its
availability in the six most commonly spoken languages in Europe
(English, French, German, Italian, Spanish, and Polish) [31]).
Topical, relevant, accurate content is more likely to rank highly
in online searches and be found. Supporting this, EuroStemCell’s
platform and resources (including factsheets and digested reads)
are optimized for search using best practices laid out by the World
Wide Web  Consortium (W3C), making it easier for search enginesropean infrastructure for communication and engagement with
16/j.semcdb.2017.08.006
well in Google (and other i.e. Yahoo and Bing) searches. To aid this
the project pays regular and close attention to search engine opti-
misation (SEO) strategies incorporating current best practices. Of
the 1.3 million users of the website in 2016, 82.7% of them found the
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Table 2
Summary of EuroStemCell’s evolving learning about audience needs.
Audience Example EuroStemCell learning regarding needs Provision
General interest
non-specialists
Families, Community groups,
school students, European
citizens
- Accessible approaches, built on the dual
foundations of plain English and
scientific review
Use of multi-media.
-  Succinct, synthesized, collated and
overarching subject-specific information
on research developments and clinical
progression
Co-production and collaboration with creative
industry professionals such as artists, writers,
graphic artists, sculptors and film-makers.
-  Credible, reliable and transparent
information sources
Writers and reviewers who can engage with senior
scientists and other primary information providers
to  help provide the ‘bigger picture’ of stem cell
research.
-  Opportunities for discussion of ideas and
questions, including online, via social
media, and face-to-face at events
Clear procedures regarding the timely updating of
research/clinical developments that are visible to
website users.
Informed
non-specialists
People affected by conditions,
care-givers, teachers, school
students, healthcare
professionals, media
professionals, policy-makers,
parliamentarians
- Lay summaries of research papers Lay summaries of individual research papers in
areas of key interest.
-  Succinct, synthesized, collated and
overarching subject-specific information
on research developments and clinical
progression
Resource review processes that include/involve
science communicators, educationalists and
people affected by conditions.
-  Credible, reliable and transparent
information sources
Writers and reviewers who can engage with senior
scientists to help to provide the ‘bigger picture’ of
stem cell research.
-  Opportunities to talk about and discuss
their thinking, ideas and questions
Clear procedures regarding the timely updating of
research/clinical developments that are visible to
readers/website users.
-  Clear information on how to get
involved with the research community
A dialogic approach to engagement events and the
promotion of that approach amongst the
EuroStemCell partnership.
-  Multi-faceted approaches, such as
online; face-to-face; interdisciplinary;
small forums; conferences; out-reach
and in-reach
Specialists Regulators, members of the
academic research community,
and stem cell companies
- Timely responses to current priorities Information that has had multiple reviewers.
-  Holistic approach to topics rather than
single issue or single viewpoint
A needs-based approach to subject matter.
-  Access to interdisciplinary networks,
stakeholder organizations and specific
experts
Multi-disciplinary approaches such as combining
social science, economics, bioethics approaches
with science.
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uite through ‘organic’ searches – they entered terms2 into a search
ngine and this led them to eurostemcell.org. The importance of
his cannot be overstated: when people are looking for information
bout stem cell research they find eurostemcell.org.
.5. Building capacity within the scientific community to
articipate in public engagementPlease cite this article in press as: J. Barfoot, et al., EuroStemCell: A Eu
stem cell research, Semin Cell Dev Biol (2017), http://dx.doi.org/10.10
EuroStemCell provides a mechanism to facilitate the sharing
f learning amongst professionals in intermediary roles (such as
ommunication officers, outreach officers and public engagement
2 Such as “stem cell therapy” “embryonic stem cell research” “what are stem cells
sed for?” “use of stem cells” Source: website analytics, 2017.Well coordinated contacts and networks
management.
practitioners), by facilitating networking, providing training and
resources (see Table 1, Section 5), and disseminating the outputs of
workshops, conferences and other events. These actions are made
possible by the co-ordinating role of the project staff and by extra
expertise drawn in from the partnership. The need for work in
this area was  recognized relatively early in the project’s develop-
ment (during the 2008–2010 phase) as it became apparent that
communications, engagement and outreach officers are key ‘influ-
encers’ of the quantity and quality of engagement actions from
a given institute. In addition the EuroStemCell project staff facil-
itate yearly ‘sharing best practice in communicating about stem
cell research’ workshops in different European cities for stem cell-ropean infrastructure for communication and engagement with
16/j.semcdb.2017.08.006
related communication/outreach professionals. This has become an
increasingly important mechanism for supporting partners in par-
ticipating in the engagement/communication effort surrounding
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replacement for more nuanced and complex forms of public
engagement. This framework is supported by research into pub-
lic engagement, albeit using different terminology. Hetland [43]
3 The deficit model in this context is defined as a process of transmission of
information from the scientific community to non-specialists with the outmoded
assumption that understanding will result in acceptance, trust in, and potentiallyARTICLESCDB-2315; No. of Pages 12
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tem cell research and increasing the impact of the EuroStemCell
roject.
.6. Embedding evaluation into all levels of the project
The actions detailed above have allowed for the promotion of the
ole and importance of evaluation in public engagement amongst
he researchers who participate in public engagement activities, a
heme which is explored in detail elsewhere in this edition [32].
valuation is used regularly to monitor user experience of, and
iewpoints regarding, the project. A core project ethos is a timely
nd structured response to the findings of this evaluation work,
esulting in changing mode of action or direction of activity in order
o strengthen the project. For example, through evaluation work
ith patient organisations we discovered that basic research, as
ell as clinical research, was of interest to them. A second dis-
overy was the negative impact of pages and text in English on
ranslated/non-English elements of the website; the website rede-
elopment undertaken in 2016 directly addressed this.
The project uses an evaluation framework developed in collab-
ration with a professional external evaluator, to assess project
utcomes from the perspectives of: the individual or end-user, net-
ork stakeholders (principally organizations or networks or their
epresentatives), and partners (for example the scientists, social
cientists, ethicists, public engagement practitioners and commu-
ication officers who are ‘official’ partners within the EuroStemCell
roject) (see Fig. 5). This takes the form of online surveys (end-users
nd stakeholders), interviews (partners) and semi-structured focus
roups (partners) at project meetings or web conferences. This is
oupled with internal monitoring of the project, for example using
ebsite analytics to monitor online activity, along with case studies
nd logging the number and nature of engagement activities across
he partnership. These evaluations have revealed important infor-
ation regarding the reach and impact of EuroStemCell but have
lso provided evidence of impact that have been used for Research
xcellence Framework case studies for the University of Edinburgh
nd in funding applications.
The evaluation actions have revealed several findings: first, the
nformation and resources provided by EuroStemCell are valued
y the different types of stakeholders, and EuroStemCell is estab-
ished as a source of reliable, accessible, credible and up-to-date
nformation. Second, the translation of the website has been vitally
mportant to the reception and reach of the project across Europe
nd beyond. Third, EuroStemCell now has a large digital footprint
hat allows extremely broad dissemination of resources and sup-
orts wide-ranging connections with diverse stakeholders. Fourth,
uroStemCell is brokering and building new networks and part-
erships amongst the scientific community, the stem cell public
ngagement community and between different disciplines. This
osters the effective sharing of best practice in stem cell research
ublic engagement across Europe and has contributed to develop-
ent of new research projects and initiatives. Examples are:
A stem cell research ‘Wikithon’ initiative, initially developed by
one EuroStemCell partner [33] then disseminated by EuroStem-
Cell to all partners along with associated guidance material.
Wikithons are concerted actions that provide training and sup-
port for the editing of wikipedia to increase the quality of online
information, and require minimal training and time commitment.
Participation of EuroStemCell partners in UniStem Day – an
initiative pioneered and led by the University of Milan [34]. UniS-
tem Day currently represents the largest single day focussed onPlease cite this article in press as: J. Barfoot, et al., EuroStemCell: A Eu
stem cell research, Semin Cell Dev Biol (2017), http://dx.doi.org/10.10
engagement of young people with stem cell research in Europe.
Initially run only in Milan, with an audience of a few hundred, in
2017 over 70 Universities across 7 European countries engaged
with over 27,000 high school students on a single day. EuroStem- PRESS
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Cell was instrumental in the growth of this initiative, through its
dissemination and coordination functions.
6. A public engagement perspective
6.1. Public engagement in the context of EuroStemCell
The National Coordinating Centre for Public Engagement defines
public engagement as “a two-way process, involving interaction
and listening, with the goal of generating mutual benefit” [35].
However, as public engagement itself is a developing field, alterna-
tive definitions exist [36–39] and it is important that each initiative
uses an operational definition of ‘public engagement’ suitable for
its own specific context. EuroStemCell draws on work by Parry et al.
[18] to use a definition of public engagement that includes:
• co-production with partners of tools and resources, with the objec-
tive of providing knowledge exchange channels in to, as well as out
of, the stem cell research community;
• fostering collaboration between interdisciplinary stakeholders; and,
• empowering both the publics and the scientific community to par-
ticipate in dialogue, deliberation and policymaking surrounding the
complex issues in this field.
Provision of scientific information has been the subject of much
discourse within the public engagement sphere. The debate cen-
tres on the need to move beyond the now outmoded ‘deficit’
model of communication,3 which uses information provision as
a central mechanism, with an underlying assumption that infor-
mation provision will generate public acceptance [40]. Indeed,
Mohr and Raman [41] and others [42] have highlighted that more
dialogue-based4 perspectives are required, in order that deeper,
more complex, and potentially more powerful public engagement
with research is achieved.
EuroStemCell’s perspective is that information provision has an
important role in public engagement. It facilitates conversation,
rather than dictating its outcome; in other words, information pro-
vision enables “manifold perspectives, visions and values that are
relevant to the science and technologies in question” – as suggested
by Mohr and Raman to be one of the goals of public engagement
[41]. Information brings relevance and context to the conversation
with audience groups that have been integral to the development
of EuroStemCell outputs. In this context, the intended outcomes of
information provision are empowerment, mutual learning, partici-
pation and dialogue. The early adoption of a dialogic (or reciprocal)
approach to knowledge-building and sharing has been critical to
the success of EuroStemCell, has been actively fostered, and will
continue to develop.
6.2. The spectrum of public engagement: playing our part but not
yours
Fig. 6 summarizes the EuroStemCell approach, which regards
information provision as an important foundation but not aropean infrastructure for communication and engagement with
16/j.semcdb.2017.08.006
approval of, that area of science.
4 Dialogue is defined here as a two-way interaction involving listening, trans-
mission and mutual participation by both/all parties. In dialogue, the perspectives,
experience and approaches of all parties are valued, the emphasis is on deliberation
and  mutual education rather than persuasion.
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Fig. 5. Stakeholder evaluation of the EuroStemCell project. The data presented form part of a stakeholder evaluation report completed in June 2016, and show opinions on
how  well EuroStemCell was  then achieving its stated outcomes in relation to information provision and educational resources (a, b); how stakeholders use the individual
resources produced by the project (c); and their rating of that resource (d). Stakeholders are defined here as partners in the EuroStemCell network or project; they represent
the  multipliers for the actions of the project. They are not the ‘end-users’ of the resources, although it is acknowledged there is overlap. For example, a representative from
a  patient advocacy organization would be termed a ‘stakeholder’ and included in this e
end-user and would be included in a separate evaluation action. This evaluation work w
December 2016. Data are based on 240 respondents from 15 countries within the networ
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aig. 6. Spectrum of public engagement. Representation of the spectrum of activity
hat  represents public engagement with research, showing associated possible out-
omes. Information is represented as foundational to other modes of engagement.
oncludes that the goal of public engagement is not to evolve from
issemination of research via dialogue about research to public par-
icipation in research [43]. Rather, they challenge the idea that these
hree models form a hierarchy, and conclude that there is a place
or all three in public engagement with science [43].
As a project, we co-ordinate the flow and exchange of infor-
ation in a timely and accessible manner, with the primary aim
f stimulating engagement and two-way communication between
he scientific community and other communities about stem cell
esearch. A useful means of conceptualizing this approach to infor-
ation provision is as follows: at one level, EuroStemCell views its
ole as providing ‘information for dialogue’; however, because anPlease cite this article in press as: J. Barfoot, et al., EuroStemCell: A Eu
stem cell research, Semin Cell Dev Biol (2017), http://dx.doi.org/10.10
thos of co-production underpins all of the information-provider
ork of the project, this can be extended to ‘information as dia-
ogue’. A recent Canadian study comments on the value of this
pproach [44], revealing that with access to well-crafted onlinevaluation, whereas the person affected by the condition would be defined as the
as undertaken to inform the redevelopment of the website which was launched
k.
communications about iPS technology, lay citizens could provide
nuanced and insightful advice to policy makers. Longstaff et al. [44]
also highlight the importance of accessible, accurate and up-to-date
information on stem cell research and conclude by encouraging
the stem cell community to continue to make their work widely
available in online formats suitable for non-specialist communities.
This approach is further supported by other smaller scale studies
such as the Patient’s Participate! Project, which identified ‘digested
reads’ of primary research materials as a priority for people affected
by conditions [45]. The dramatic increase in eurostemcell.org and
associated social media usage also speaks to the validity of this
approach. In the context of stem cell research, developmental biol-
ogy and regenerative medicine, EuroStemCell therefore fulfils a
part of the public engagement imperative but does not provide the
whole. There is space in this arena for others in the scientific com-
munity to also take up the mandate with their own  approaches,
expertises and ideas.
7. The future necessity for ongoing public engagement
with stem cell research
Initially, advances in embryonic stem cell research caused
debate and a rethinking of policy and regulations due to the use
of embryos for research and the potential for human reproductive
cloning. Some thought that with the discovery of iPS cells, ethical
debates were resolved, but this was not the case [12,21]. iPS tech-ropean infrastructure for communication and engagement with
16/j.semcdb.2017.08.006
nologies have simply added to the ethical matrix, revealing more
complexities in the ethical, social and moral dimensions of stem
cell research. Rather than becoming less contentious over time, as
both science and clinical translation progress, new ethical issues
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re often revealed that must be addressed through national and
nternational policies [21].
Within this societal context, and in light of the high public pro-
le of stem cell research, sustained and continued high-quality
ublic engagement with stem cell research is vital [21,46], espe-
ially as the nature of patienthood, health, patient activism (efforts
o change the ‘norm’ in healthcare provision) and risk evalua-
ion evolve within the digital context [47]. This necessitates public
ngagement with stem cell research that spans the whole spec-
rum of engagement activity [18, Fig. 6], including the two-fold
ole EuroStemCell can play in information provision for digital
ngagement and capacity building in the scientific and science
ommunications communities. However, EuroStemCell’s approach
f coordinated provision of synthesized, co-produced and evalu-
ted information from the scientific, social science, and bioethical
ommunities is part of a much bigger picture and indeed is only
ne aspect of the EuroStemCell project. Looking to the future, the
roject is now embarking on several large digital initiatives that
ill bring together different areas of expertise to help forge new
ays of thinking about how ‘decision makers’ can be supported
nd resourced. Clearly, deliberation and decision-making are multi-
actorial issues, and once again EuroStemCell seeks to proactively
lay a part whilst acknowledging that our role is only part of the
rocess [44,48]. The involvement of many interdisciplinary sectors
upports complex, meaningful and holistic engagement – a neces-
ity as this fast-moving field continues to innovate and evolve.
Our experience to date with the EuroStemCell project has taught
s that there is a strong appetite for engagement amongst the many
nd diverse publics, and that by working in partnership with net-
orks and multi-stakeholders, it is possible for a relatively small
roject to achieve large international reach. Our hope is that others
n the scientific community also take up this mandate to provide
o-ordinated and collaborative public engagement efforts in their
wn fields.
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